Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 993-1002

  Afdhal, Nezam H ^a   Keaveny, Andrew P ^a   Cohen, Steven B ^a   Nunes, David P ^a   Maldonado, Norris ^a   O'Brien, Michael ^a   Stone, Phillip J ^a  

^a NONE

Author keywords

Cirrhosis; Desmosine; Fibrosis; Hepatitis C; Hydroxylysylpyridinoline; Isodesmosine; Procollagen peptide III

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN; CREATININE; DEOXYPYRIDINOLINE; DESMOSINE; ELASTIN; ISODESMOSINE; PROCOLLAGEN; PYRIDINOLINE;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE DILUTION ASSAY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RECEIVER OPERATING CHARACTERISTIC; URINE LEVEL;

EID: 0030780733     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80142-0     Document Type: Article

References (34)

1. Schiff ER, Schiff L. Needle biopsy of the liver. Schiff L, Schiff ER. 7th ed. Diseases of the Liver. 1993;216-225 Lippincott Co, Philadelphia.
2. Schuppan D, Stölzel U, Oesterling C, Somasundaram R. Serum assays for liver fibrosis. J Hepatol. 22:1995;82-88.
3. Plebani M, Burlina A. Biochemical markers of liver fibrosis. Clin Biochem. 24:1991;219-239.
4. Tanikawa K. Serum markers for hepatic fibrosis and related liver pathology. Path Res Pract. 190:1994;960-968.
5. Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol. 24:1996;148-154.
6. Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Catterall AP, et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet. 342:1993;895-898.
7. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology. 20:1994;780-787.
8. Guéchot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R. Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of α-interferon therapy. J Hepatol. 22:1995;22-26.
9. Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, et al. α-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol. 18:1993;112-118.
10. Collazos J, Díaz F. Role of the measurement of serum procollagen type III N-terminal peptide in the evalution of liver diseases. Clin Chim Acta. 227:1994;37-43.
11. Haydon GH, Plevris JN, Simpson KJ, Dawkes R, Bouchier IAD, Hayes PC. Serum hyaluronic acid levels reliably predict the presence of cirrhosis in patients with chronic liver disease. [Abstract] Gastroenterology. 110:1996;A1208.
12. Parés A, Caballería J. Metabolism of collagen and other extracellular proteins. McIntyre N, Benhamou J-P, Bircher J, Rizzetto M, Rodes J. Oxford Textbook of Clinical Hepatology. 1991;199-211 Oxford University Press, Oxford.
13. Sandberg LB, Soskel LT, Leslie JG. Elastin structure, biosynthesis and relation to disease states. N Engl J Med. 304:1981;566-567.
14. Stone PJ, Lucey EC, Snider GL, Franzblau C. Effect of diet on urinary excretion of desmosine and hydroxylysyl pyridinoline. Am J Respir Crit Care Med. 149:1994;174-177.
15. Stone PJ, Bryan-Rhadfi J, Lucey EC, Ciccolella DE, Crombie G, Faris B, et al. Measurement of urinary desmosine by isotope dilution and high performance liquid chromatography. Correlation between elastase-induced air-space enlargement in the hamster and elevation of urinary desmosine. Am Rev Respir Dis. 144:1991;284-290.
16. Stone PJ, Bryan-Rhadfi J, Shaw HA, Franzblau C. Isolation of hydroxylysyl pyridinoline, a mature collagen crosslink, from neonatal rat aorta smooth muscle cell cultures. Matrix. 12:1992;381-387.
17. Stone PJ, Gottlieb DJ, O'Connor GT, Ciccolella DE, Breuer R, Bryan-Rhadfi J, et al. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 151:1995;952-959.
18. Stone PJ, Korn JH, North H, Lally EV, Miller LC, Tucker LB, et al. Crosslinked elastin and collagen degradation products in urine of patients with scleroderma. Arthr Rheum. 38:1995;517-524.
19. Stone PJ, Morris TA, Franzblau C, Snider GL. Preliminary evidence that augmentation therapy diminishes degradation of crosslinked elastin in alpha-1-antitrypsin-deficient humans. Respiration. 62:1995;76-79.
20. Pugh RNH, Murray-Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
21. Schlemmer A, Hassager C, Jensen SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women. J Clin Endocrinol Metab. 74:1992;476-480.
22. Bianchi L, Gudat F. Chronic hepatitis. McSween RNM, Anthony PP, Scheur PJ, Burt AD, Potman BC. Pathology of the Liver. 1994;349 Churchill Livingstone, New York.
23. Beardsworth LJ, Eyre DR, Dickson IR. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res. 5:1990;671-676.
24. Ramadori G, Zohrens G, Manns M, Rieder H, Dienes HP, Hess G, et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentrations in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest. 21:1991;323-330.
25. Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem. 34:1988;715-718.
26. Jouet P, Roudot-Thoraval F, Dhumeaux D, Metreau JM. Comparative efficacy of interferon alfa in cirrhotic and non-cirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology. 106:1994;686-690.
27. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
28. Gottlieb DJ, Stone PJ, Sparrow D, Gale M, Weiss ST, Snider GL, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: The Normative Aging Study. Am J Respir Crit Care Med. 154:1996;1290-1295.
29. Stone PJ, Konstan MW, Berger M, Dorkin HL, Franzblau C, Snider GL. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med. 152:1995;157-162.
30. Colwell A, Russell RGG, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest. 23:1993;341-349.
31. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Min. 8:1990;87-96.
32. Hayasaka A, Ilda S, Suzuki N, Kondo F, Miyazaki M, Yonemitsu H. Pyridinoline collagen crosslinks in patients with chronic viral hepatitis and cirrhosis. J Hepatol. 24:1996;692-698.
33. Ricard-Blum S, Bresson-Hadni S, Vutton DA, Ville G, Grimaud JA. Hydroxypyridinium collagen crosslinks in human liver fibrosis: study of alveolar echinococcosis. Hepatology. 15:1992;599-602.
34. Ricard-Blum S, Bresson-Hadni S, Guerret S, Grenard P, Voile PJ, Ristell L, et al. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology. 111:1996;172-182.